about
Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects.Divergent Effects of Dioxin- or Non-Dioxin-Like Polychlorinated Biphenyls on the Apoptosis of Primary Cell Culture from the Mouse Pituitary Gland.The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.PPARgamma in placental angiogenesis.Ectopic expression of FSH receptor isoforms in neoplastic but not in endothelial cells from pancreatic neuroendocrine tumors.Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's disease.Risk Factors for Development of Coronary Heart Disease in Patients with Acromegaly: A Five-Year Prospective StudyPrognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNETCardiac extrinsic apoptotic pathway is silent in young but activated in elder mice overexpressing bovine GH: interplay with the intrinsic pathway.Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormoneHigh prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imagingApoptosis is reduced in the colonic mucosa of patients with acromegalySomatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism [corrected] due to MEN 1-like syndromeIdentification of acromegalic patients at risk of developing colonic adenomasPituitary autoimmunity is associated with hypopituitarism in patients with primary empty sellaThe beneficial effect of acromegaly control on blood pressure values in normotensive patientsLower prolactin levels during cabergoline treatment are associated to tumor shrinkage in prolactin secreting pituitary adenoma
P50
Q34128753-623018F8-2BD8-4CDA-BD45-98558988E73CQ35890596-C50FB4E8-6D8F-402C-881A-90796473F81EQ40982205-9289585E-A7C9-43B5-AC7D-E211D38BB136Q42920208-1AA1F8B0-BE96-4785-869E-682C73C7CC43Q44418951-F5D3531E-49B3-40D5-A8AD-DE651DA54CBDQ46457281-781CA758-6944-4D54-B868-F500133197BCQ52651698-960263E5-4444-4A0F-B206-BD47B9D36D9AQ54564410-B2C78128-320F-4A98-9482-43A0788FE1A6Q60625222-9704F0EA-5F63-401F-A3F5-562CDBCE727CQ61685132-C1D9DE15-ABA7-4E0F-9938-264609F5728DQ64974110-A6F78705-46B8-469B-8634-1FA5B67FAF42Q79248711-A82BF220-A00F-4A3B-8DFD-E1DFE09733E4Q81248195-6581CE9E-6B0B-4550-AB8F-CA639A77D3F5Q81604820-C3BAC9FF-AB4C-48C3-B0BA-A5C2025D89D0Q82039267-6FB583AE-30F6-4941-BAAE-AD5463974999Q82434367-04046430-1A8F-4CB4-850D-C0430C51D58DQ84218635-501CD991-9772-433C-A87E-19B52ADC6730Q87503280-2A3DC922-BDB5-4E40-9A39-8F55E422431BQ95515963-2DB9FCCE-AB51-41A4-97F2-C4368DBDD69E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2497-5825
@en
name
Chiara Sardella
@ast
Chiara Sardella
@en
Chiara Sardella
@es
Chiara Sardella
@nl
type
label
Chiara Sardella
@ast
Chiara Sardella
@en
Chiara Sardella
@es
Chiara Sardella
@nl
prefLabel
Chiara Sardella
@ast
Chiara Sardella
@en
Chiara Sardella
@es
Chiara Sardella
@nl
P106
P1153
9845570300
P21
P31
P496
0000-0003-2497-5825